SSX2 and AL amyloidosis: Taylor et al. reported the detection of SSX2 mRNA in 24% of bone marrow samples of multiple myeloma patients (total: 114) [36], while Atanackovic et al. detected SSX2 in 12%–16% of bone marrow samples with significant plasma cell infiltration, but not in bone marrows of healthy donors [33], [37].